Increasing circulating levels of Acrp30 may enhance insulin sensitivity and facilitate the management of blood glucose levels, positioning Acrp30 as a promising therapeutic target for diabetes mellitus treatment [284]. Here, ADIPOQ is linked to diabetes mellitus.